Fig. 1: Outcome of patients with t-MDS according to different tools for classification and prognosis.
a outcome according to WHO 2016, b outcome according to IPSS-R, c Outcome according to cytogenetic IPSS-R risk categories.
Fig. 1: Outcome of patients with t-MDS according to different tools for classification and prognosis. | Leukemia
